Open to all scientists researching new therapeutics in Cambridge and the local area.
The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.
Next event:
Host: Domainex
Date: Tuesday 29th June 2021
Location: This event will take place online. Please register on Eventbrite and joining details will be circulated prior to the event.
Programme
18:00 – Welcome: Dr Tom Mander
Session Chair: Dr Judith Hills
18:10 – Professor Daniel Longley, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast
Talk title: First-in-class inhibitors of the major cell death regulator, FLIP
18:30 – Professor Laurence H. Pearl PhD FRS FMedSci, Professor of Structural Biology, Genome Damage and Stability Centre, University of Sussex
Talk title: Phosphorylation-dependent assembly of the DNA damage response
18:50 – Dr Eddy Littler, Chief Operating Officer, ReViral Ltd., Stevenage
Talk title: Development of medicines for Respiratory Virus infections ('flu' and RSV); lessons learnt for SARS-CoV-2
19:10 – Post-talk discussion and additional Q&A
19:45 – Meeting close
Event registration: https://camntfjune2021.eventbrite.co.uk
